Friday, August 29, 2014 10:08:11 AM
From the Moore plan:
"The MMP Plan also sets aside as a preference the August 2012 TPL agreement with Alliacense, Patriot and PDS, that established Alliacense as the commercialization entity for the MMP Portfolio. With the 2012 Agreements set aside, and Alliacense no longer authorized to carry out MMP commercialization, all MMP licensing and commercialization rights revert to TPL under the 2005 foundational agreement between and among TPL, Patriot and Mr. Moore, still in effect and remaining in effect as an assumed contract of Debtor TPL, that gave TPL commercialization rights to the MMP Portfolio and established PDS to monitor and supervise TPL’s performance and to collect MMP revenues."
Recent CPMV News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 05:17:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 06:44:38 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM